Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Critical Mineral Executive Order Issued by President Donald Trump (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Healthcare Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

Recent & Breaking News (TSXV:VM)

Voyageur Pharmaceuticals Ltd Submits Fourth Radiographic Contrast Product to Health Canada for Registration

TheNewsWire January 10, 2020

Voyageur Announces Closing of Financing, Issuing of Stock Options and Extension of Warrants

TheNewsWire December 30, 2019

Voyageur Announces Private Placement Extension and New Flow-Through Financing

TheNewsWire December 23, 2019

Voyageur Pharmaceuticals, Upgrades Frances Creek Barite to 98% BaSO4 with First Stage Gravity Separation

TheNewsWire December 18, 2019

Voyageur Minerals Ltd. Announces:

TheNewsWire December 10, 2019

Voyageur Closes Second Tranche of Non-Brokered Private Placement, Announces Private Placement Extension and Resignation of Director

GlobeNewswire December 5, 2019

Voyageur Minerals retains Frontier Merchant Capital Group for marketing and financial communication services

GlobeNewswire November 7, 2019

Voyageur Minerals' Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration

GlobeNewswire November 5, 2019

Voyageur Minerals Announces Mailing of Materials for the Annual and Special Meeting of Shareholders to be held November 12th, 2019 and a New Private Placement Financing

GlobeNewswire October 10, 2019

Voyageur Minerals Ltd Joint Venture Company, ImagingX Pharmaceuticals, Submits Second Barium Contrast Product to Health Canada for Registration

GlobeNewswire October 4, 2019

Voyageur Announces the Closing of Private Placements

GlobeNewswire September 26, 2019

Voyageur Minerals Board of Director Changes

GlobeNewswire September 12, 2019

Voyageur Minerals Appoints Pharmaceutical Expert to the Board of Directors

GlobeNewswire August 12, 2019

Voyageur Minerals' Joint Venture Company ImagingX Pharmaceuticals, Submits its First of Three Barium Contrast Products to Health Canada for Registration

GlobeNewswire August 8, 2019

Voyageur Minerals Announces Director Changes

GlobeNewswire August 7, 2019

Voyageur Closes First Tranche of Non-Brokered Private Placement

GlobeNewswire July 29, 2019

Voyageur Announces Financing of $400,000

GlobeNewswire July 11, 2019

Voyageur Minerals Announces Management Change with New CEO and Director Appointments

GlobeNewswire July 4, 2019

Voyageur Announces the Closing of a $240,651.52 Private Placement

GlobeNewswire May 8, 2019

Voyageur Announces Financing of $400,000

GlobeNewswire April 26, 2019